Company ProfilePremium

Advent Computer Services Limited

Company Profile Analysis

Ticker: 531429.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Advent Computer Services Limited - Company showcase

Year Founded & Workforce

1984

4 Employees

Advent Computer Services Limited logo

Advent Computer Services Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Advent Computer Services Limited Overview

Advent Computer Services Limited is a Chennai-based legacy software company founded in 1984 by former IBM systems engineer Michael Arul. It started as a 100% export-oriented unit building business application software for IBM's midrange S/38 and, later, AS/400 platforms, and its flagship ADS 400 was a distribution and financial management suite. The company later tried several pivots: L&T Information Technology managed its operations under a 1999 MoU, it bought two small software firms in 2000, and in 2003 it pursued set-top-box and embedded technology with Tuxia GmbH and TVS Electronics. It most recently positioned itself in secure mobile banking and remote health monitoring. None of these produced meaningful revenue in recent years. Operating revenue fell from ₹0.48 Cr in FY2016 to zero in FY2020, and the board pursued a stated acquisition-led revival that was never executed. The equity was compulsorily delisted from BSE in November 2024. Today the company is best described as a dormant, foreign-promoter-controlled micro-entity whose main relevance to minority shareholders is the regulatory exit process.


The company's own description (latest annual report, FY2020)

The FY2020 Annual Report's statutory MGT-9 extract classifies the company's principal business as "Computer Programming, Consultancy and Related Activities" (NIC code 620) and gives no turnover percentage for it, because the company recorded no operating revenue in FY2020. The Management Discussion & Analysis (MD&A) in the same report frames the business plan in these terms (paraphrased):

  • The company needs to build execution capability in current IT and telecom platforms to win profitable project revenue. Management views acquiring existing companies with order books and proven delivery teams as the best route, and says it was qualifying one or more acquisition targets.

  • Management stated that it had identified investors willing to fund such acquisitions.

  • The company had been working to become the execution partner for an international company launching a secure mobile financial transaction platform for banks in India.

  • Long-term, it aims to leverage its mobile banking and payment platform technology. Short-term, it would take on any IT project that delivers revenue or profit. It also saw an opportunity in remote health monitoring services.

  • The main threat identified was the ability to raise capital for the acquisition strategy.

  • Human resources: the company outsources the manpower it needs, so its own headcount is very small.

The company's website, as summarised by Screener, describes two service lines:

  1. Mobile Banking. The company claims access to telecom technologies and products that give it a competitive edge in delivering secure mobile banking services.

  2. Remote Health / Telehealth. Independent remote and mobile health monitoring services meant to help physicians detect and analyse symptoms early. Listed offerings are remote and mobile ECG monitoring, voiding diary monitoring, blood pressure monitoring, blood glucose monitoring, fetus monitoring, intelligent infant management, and patient follow-up and medication management.

Business model and revenue model

DimensionCharacterisationEvidence
Revenue model (historical)Software product licensing and implementation (ADS 400, retail and distribution packages) for export markets, plus IT servicesCompany history (1984–1999)
Revenue model (FY2016–FY2019)Small IT consulting and support services. FY2019 sales and services were ₹10.69 lakhAR FY2020 Directors' Report
Revenue model (FY2020 onward)No operating revenue. FY2020 other income was ₹0.44 lakhAR FY2020
Product vs. service vs. subscription vs. licensing mixNot disclosed by line. The single reported segment is software development and salePitchBook description; AR MGT-9
Value-chain positionHistorically an independent software vendor (ISV) inside the IBM midrange ecosystem. Recently an aspiring systems integrator or execution partner for third-party platforms (mobile banking) and a service provider using third-party telehealth devices and technologyAR FY2020 MD&A; company website summary
Customer typesHistorically wholesale distribution and food manufacturing enterprises (e.g., the Australian beta site for a Bunge Corporation subsidiary) and large government or research computer installations in India. Recent customers not disclosed. FY2019 included a one-time related-party IT consulting contract with CCG Technologies India Pvt Ltd (value not disclosed)ClearTax company background; AR FY2020 AOC-2
End-marketsBanking and financial services (mobile banking), healthcare (remote monitoring), enterprise IT servicesCompany website; AR FY2020 MD&A
GeographyIndia only, per PitchBook. Foreign exchange earnings were nil in FY2020PitchBook; AR FY2020 Schedule E

Independent characterisation

Based on the filings, Advent stopped being an operating software company in a commercial sense several years ago. The evidence is consistent across sources:

  • Operating revenue declined from ₹0.48 Cr (FY2016) to ₹0.46 Cr (FY2017), ₹0.16 Cr (FY2018), ₹0.11 Cr (FY2019) and nil (FY2020), with nil revenue in each of the first three quarters of FY2021 (Screener, from BSE filings).

  • Four employees at 31 March 2020, with delivery capacity outsourced (AR FY2020).

  • Zero R&D expenditure in FY2020 and no imported technology in the preceding three years (AR FY2020 Schedule E).

  • The Managing Director drew no remuneration because of losses (AR FY2020).

  • Unsecured borrowings rose from ₹0.73 Cr (FY2016) to ₹2.59 Cr (FY2020) and largely funded operating cash burn (Screener; AR MGT-9 indebtedness table).

  • The balance sheet is dominated by ₹12.96 Cr of fixed assets plus ₹3.85 Cr of capital work-in-progress, which were consolidated into ₹16.80 Cr of fixed assets by September 2020. Depreciation on these was essentially nil from FY2017 to FY2020 (Screener). Their nature is not specified in the sources reviewed. Analytically, they look like capitalised technology or marketing rights rather than productive tangible assets, and they produced no revenue.

In short, the "mobile banking" and "telehealth" positioning described aspirations, not operating businesses. With the November 2024 compulsory delisting, the company's status as a public-market entity has ended unless the delisting is reversed.

Strategy

Stated strategy (FY2020 Annual Report, paraphrased themes)

  1. Acquisition-led capability building. Acquire IT/telecom companies with existing business and proven execution teams, so the company gains revenue, profit and delivery capability in the short term. Management said it was qualifying targets and had identified willing investors.

  2. Execution partnership in mobile financial transactions. Become the Indian execution partner for an unnamed international secure mobile financial transaction platform for banks.

  3. Remote health monitoring rollout. Pursue what management called a significant opportunity in remote health monitoring services.

  4. Opportunistic IT projects. In the short term, take on any IT project that is revenue- or profit-accretive.

  5. Cost discipline. Keep costs manageable given pandemic-era economic conditions.

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

No strategic initiatives, partnerships, transformation programmes, ESG commitments, cost programmes or financial targets have been publicly announced by the company in this period. The only material corporate event found is BSE's compulsory delisting order effective 27 November 2024.

Management guidance and medium-term targets

Not publicly disclosed. The company has never issued quantitative revenue or margin guidance in the sources reviewed. The FY2020 MD&A expressed a qualitative view that the acquisition approach would reduce business and marketing risk.

Assessment

The strategy depended on external capital, which the MD&A itself named as the main threat. No acquisition, capital raise or platform contract was announced after September 2020, and the company subsequently fell out of listing compliance, so the stated strategy should be treated as unexecuted. The delisting removes the listed-equity currency that an acquisition strategy would normally rely on.

Products & Services

All products sit within the single software and IT services segment. The company does not disclose pricing, version years or revenue by product. Commercial status is shown as stated or inferred from filings.

Historical enterprise software (IBM midrange era)

Product / offeringDescription & capabilitiesTarget customerLaunch / latest yearPricingCommercial status
S/38 business application softwareExport-oriented business application software for the IBM System/38Wholesale distribution enterprises using IBM S/381984–1988—Legacy; superseded by ADS 400
ADS 400Integrated distribution management and financial software for the IBM AS/400. Beta in Melbourne in 1991 at a Bunge subsidiary; launched in South East Asia in 1995Wholesale distributors and food manufacturers/distributorsDevelopment from 1988; beta 1991; SE Asia launch 1995Not disclosed (licence-based, inferred)No disclosed revenue in recent filings; presumed legacy/dormant
Retail & distribution packagesProprietary packages for retail and distribution businessesIndian and overseas retailers and distributors1,996—No disclosed recent revenue

Embedded and consumer-electronics technology (2003 initiative)

Product / offeringDescription & capabilitiesTarget customerYearPricingCommercial status
Tuxia-based set-top box technologyAdvent was to supply Tuxia GmbH (Germany) technology for set-top boxes built to Advent's specifications by TVS Electronics, with planned capacity scaling to 60,000 units per monthIndian and global set-top box market2003 MoU—Outcome not publicly disclosed; no related revenue in recent filings
Exclusive Indian marketing rights to Tuxia products and technologiesRights acquired through the issue of 1.84 million shares to CCG Global Ltd (Mauritius), plus five years of support and upgrades through 0.46 million shares to Tuxia GmbH—2,003Share-settledStatus not disclosed

Mobile banking

OfferingDescription & capabilitiesTarget customerYearPricingCommercial status
Secure mobile banking / mobile financial transaction servicesCompany claims access to telecom technologies and products for secure mobile banking. MD&A FY2020 says it aimed to be the Indian execution partner for an international company's secure mobile financial transaction platform for banks (partner not named)Indian banksPositioning since at least the late 2010s (exact year not disclosed)—Pre-revenue; no contract disclosed

Remote health monitoring (telehealth)

OfferingDescriptionTarget customerStatus
Remote & Mobile ECG Monitoring SystemRemote cardiac rhythm monitoring for physician reviewPhysicians, hospitals, patients with cardiac conditionsListed on website; no disclosed revenue
Remote & Mobile Voiding Diary Monitoring SystemRemote urological voiding diary captureUrologists and patientsListed; no disclosed revenue
Remote & Mobile Blood Pressure Monitoring SystemRemote BP trackingHypertension patients and cliniciansListed; no disclosed revenue
Remote & Mobile Blood Glucose Monitoring SystemRemote glucose trackingDiabetes patients and cliniciansListed; no disclosed revenue
Remote & Mobile Fetus Monitoring SystemRemote fetal monitoringObstetricians and expectant mothersListed; no disclosed revenue
Remote & Mobile Intelligent Infant Management SystemInfant health monitoring and managementPaediatric care providers and parentsListed; no disclosed revenue
Patient Follow-up & Medication Management SystemPost-discharge follow-up and medication adherenceHospitals and clinicsListed; no disclosed revenue

Specifications, device partners, regulatory approvals (e.g., CDSCO medical-device registration) and launch years for the telehealth systems are not publicly disclosed. The FY2020 MD&A calls remote health monitoring an opportunity, not an operating line.

IT consulting and support services

OfferingDescriptionEvidence
IT consulting & support for graphical user interface (GUI)One-time related-party contract with CCG Technologies India Pvt Ltd (in which the MD has significant influence), approved by the board on 30 May 2019. Value not disclosedAR FY2020 Form AOC-2
General IT projectsMD&A: short-term opportunity to take on any IT project that delivers revenue or profitAR FY2020 MD&A

Financial Narrative

Income statement

Sources: Screener P&L; AR FY2020 Directors' Report (FY2020 total income ₹0.44 lakh, total expenditure ₹19.60 lakh, loss ₹19.16 lakh; FY2019 total income ₹10.69 lakh, expenditure ₹54.41 lakh, loss ₹43.72 lakh). Gross profit is not reported because the company presents no cost-of-goods line. Diluted EPS equals basic: no dilutive instruments were outstanding, and the AR confirms no convertible warrants.

Margins and growth

Revenue growth for FY2016 is computed on FY2015 revenue of ₹0.31 Cr (Screener). Margins are undefined in FY2020 because revenue was zero. Revenue CAGR FY2016–FY2019 (3 years) is approximately -38.8% a year (computed: (0.11/0.48)^(1/3) − 1). The FY2016–FY2020 CAGR is not meaningful (terminal revenue zero). Screener reports TTM sales growth of -100% and 10-year compounded profit growth of -3%.

Balance sheet

Sources: Screener balance sheet; AR FY2020 MGT-9 indebtedness table. Unsecured loans were ₹24,382,129 at 1 April 2019 and ₹25,936,082 at 31 March 2020, with no secured loans or deposits. The short/long split and the lender identity were not found in the extracts reviewed. Screener shows total borrowings of ₹2.65 Cr against the AR's ₹2.59 Cr of unsecured principal; the difference may be other borrowing-type liabilities. Book value per share is computed as net worth ÷ 16.27 million shares; Screener shows ₹8.77 (latest). The working capital proxy is an analytical approximation from aggregated lines, not a reported figure. Sundry debtors were ₹82.15 lakh at 31 Mar 2020 (AR MD&A). Cash and equivalents are not separately disclosed in the sources reviewed. At 30 Sep 2020 the half-year balance sheet showed fixed assets of ₹16.80 Cr and CWIP of nil (CWIP capitalised), net worth of about ₹14.28 Cr and borrowings of ₹2.66 Cr.

Cash flow

Source: Screener cash flow (from BSE filings). The AR FY2020 confirms nil expenditure on fixed assets in FY2020, no dividend, and no buyback.

Ratios

ROE, ROA, debt/equity and asset turnover are computed from the tables above (year-end balances). ROCE, debtor days and cash conversion cycle come from Screener; the CCC equals debtor days because there are no inventories or payables days. ROIC and current ratio are not computed because the asset/liability split is undisclosed. Net debt/EBITDA is not meaningful (negative EBITDA, cash undisclosed). FY2019 interest coverage is undefined (interest rounds to zero). Interest coverage FY2018 = -0.52/0.03; FY2020 = -0.18/0.01 (approximate, rounded inputs).

Partial FY2021 (latest available interim data)

Source: Screener quarterly results (BSE filings). Trailing-twelve-month net loss to Dec 2020: ₹0.16 Cr. No later results were located.

Commentary: trends, inflections and drivers

Revenue collapse (FY2017–FY2020). FY2016 was the last year with revenue near ₹0.5 Cr, and the company was only marginally profitable at a ₹0.02 Cr operating profit. The FY2018 inflection, when revenue fell 65% to ₹0.16 Cr, coincided with a sharp rise in the cost base (expenses rose to ₹0.65 Cr from ₹0.45 Cr). The result was the largest loss in the dataset, ₹0.52 Cr. Revenue then fell to ₹10.69 lakh in FY2019 and to zero in FY2020. The AR attributes no specific cause beyond calling the year "challenging". Analytically, the drivers were the end of legacy service contracts, no new product traction in mobile banking or telehealth, and a deliberate shift to an acquisition-led strategy that was never funded.

Cost containment (FY2020–FY2021). Expenses fell 67% in FY2020 (₹54.41 lakh to ₹19.60 lakh), which narrowed the loss to ₹19.16 lakh. The MD drew no salary. The two KMPs (CFO and Company Secretary) were each paid ₹1.81 lakh, and independent directors received sitting fees of ₹2,000 per meeting. Quarterly costs of ₹2–8 lakh in FY2021 suggest the company was being run mainly to keep listing compliance alive.

Funding of losses through unsecured debt. Cumulative operating cash burn of about ₹1.88 Cr over FY2017–FY2020 was funded almost entirely by financing inflows of about ₹1.92 Cr, with unsecured borrowings rising more than 3.5x from ₹0.73 Cr to ₹2.65 Cr. Leverage is modest against the book equity of ₹14.33 Cr, but that equity is itself backed largely by non-earning fixed assets (see below), so economic leverage is materially higher than the 0.18x book ratio suggests.

Asset quality: the central analytical issue. Of the ₹17.88 Cr asset base at FY2020, ₹16.81 Cr (94%) is fixed assets plus CWIP that have generated no revenue and attracted essentially no depreciation since FY2017. The auditor's report carried no qualification for FY2020 (AR Directors' Report). Even so, an asset base of this size with no amortisation, alongside zero revenue, raises a significant question of whether an impairment test under Ind AS 36 would support the carrying value. If these assets were fully impaired, net worth would turn negative (about -₹2.5 Cr). The nature of the assets is not disclosed in the sources reviewed. A plausible link to the 2003 share-settled acquisition of Tuxia marketing rights and to the CWIP capitalised in FY2011 and again in H1 FY2021 is an analytical inference, not a disclosed fact.

Receivables risk. Sundry debtors of ₹82.15 lakh at March 2020 were about 7.7x FY2019 revenue, and Screener's debtor days rose from 175 (FY2016) to 2,920 (FY2019). Analytically, these receivables are probably stale and of doubtful recoverability.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Results by Segment and Revenue by Segment (%)

MetricFY2018FY2019FY2020

Software development & services segment revenue (INR Cr)

0.160.110.00

Segment share of total operating revenue (%)

100100100

Segment operating profit (EBITDA, INR Cr)

-0.49-0.43-0.18

Segment pre-tax profit (INR Cr)

-0.52-0.43-0.19

Segment operating margin (%)

-306.25-390.91—

Segment revenue YoY growth (%)

-65.22-31.25-100.00

Income Statement and Per-Share Data

MetricFY2016FY2017FY2018FY2019FY2020

Revenue from operations (INR Cr)

0.480.460.160.110.00

Other income (INR Cr)

0.000.000.000.000.0044

Total expenses excl. interest & depreciation (INR Cr)

0.460.450.650.540.18

EBITDA / operating profit (INR Cr)

0.020.01-0.49-0.43-0.18

Depreciation (INR Cr)

0.010.000.000.000.00

Interest (INR Cr)

0.000.000.030.000.01

Profit before tax (INR Cr)

0.010.01-0.52-0.43-0.19

Tax (INR Cr)

0.000.000.000.000.00

Net profit (INR Cr)

0.010.00-0.52-0.44-0.19

EPS basic (INR)

0.010.00-0.32-0.27-0.12

EPS diluted (INR)

0.010.00-0.32-0.27-0.12

Dividend per share (INR)

00000

Margin Analysis (%)

MetricFY2016FY2017FY2018FY2019FY2020

Revenue growth YoY (%)

54.84-4.17-65.22-31.25-100.00

EBITDA margin (%)

4.172.17-306.25-390.91—

Operating (EBIT) margin (%)

2.082.17-306.25-390.91—

Net margin (%)

2.080.00-325.00-400.00—

Balance Sheet and Per-Share Data

MetricFY2016FY2017FY2018FY2019FY2020

Total assets (INR Cr)

17.2117.6418.3118.0217.88

Fixed assets, net (INR Cr)

12.9612.9612.9612.9612.96

Capital work-in-progress (INR Cr)

3.853.853.853.853.85

Other assets incl. receivables & cash (INR Cr)

0.400.831.501.211.07

Equity share capital (INR Cr)

16.2716.2716.2716.2716.27

Reserves & surplus (INR Cr)

-0.79-0.79-1.31-1.75-1.94

Total equity / net worth (INR Cr)

15.4815.4814.9614.5214.33

Total borrowings (INR Cr)

0.731.262.442.592.65

Other liabilities (INR Cr)

1.000.900.910.910.90

Approx. working capital = other assets − other liabilities (INR Cr)

-0.60-0.070.590.300.17

Book value per share (INR)

9.519.519.198.928.81

Cash Flow

MetricFY2016FY2017FY2018FY2019FY2020

Operating cash flow (INR Cr)

0.00-0.53-0.62-0.60-0.13

Capex / investing cash flow (INR Cr)

-0.010.000.00-0.010.00

Free cash flow (INR Cr)

-0.01-0.53-0.62-0.61-0.13

Financing cash flow (INR Cr)

0.000.531.180.160.05

Net change in cash (INR Cr)

-0.010.000.56-0.45-0.08

Dividends paid (INR Cr)

00000

Share buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2016FY2017FY2018FY2019FY2020

ROE (%)

0.060.00-3.48-3.03-1.33

ROA (%)

0.060.00-2.84-2.44-1.06

ROCE (%) (Screener)

0.060.06-2.87-2.49-1.06

Debt / equity (x)

0.050.080.160.180.18

Interest coverage (EBIT/interest, x)

——-17.33—-18.00

Asset turnover (x)

0.0280.0260.0090.0060.000

Debtor days

174.90531.631,756.562,920.00—

Cash conversion cycle (days)

174.90531.631,756.562,920.00—

Income Statement and Per-Share Data (Quarterly)

MetricQ1FY2021Q2FY2021Q3FY2021

Revenue (INR Cr)

0.000.000.00

Expenses (INR Cr)

0.020.030.08

Net profit (INR Cr)

-0.02-0.03-0.08

EPS (INR)

-0.01-0.02-0.05

Revenue by Region and Revenue by Region (%)

RegionFY2018FY2019FY2020

India revenue (INR Cr)

0.160.110.00

Overseas revenue (INR Cr)

——0.00

India share of revenue (%)

100100—

Capital Markets

ItemDetail

Current listing

Delisted from BSE effective 27 Nov 2024; on BSE Dissemination Board

Last traded price

₹2.82 (28 Feb 2022)

Implied market cap at last trade

₹4.59 Cr

Price/book at last trade

0.32x (Screener, book value ₹8.77)

52-week range (as last captured by an aggregator)

₹4.52 high / ₹1.37 low (date basis unclear)

1-year / 3-year / 5-year performance (to Oct 2026)

Not meaningful: no trading since Feb 2022. Screener shows 5-year stock price CAGR of 2% and 10-year of 0% (as of last trade)

Analyst consensus

None. No sell-side coverage. Trendlyne shows an informal community poll (3 votes: 33% buy, 67% hold), which is not analyst coverage

Dividend history

No dividends in any year FY2009–FY2020 (payout 0%; Screener; AR FY2020)

Dividend policy

Not formally disclosed; dividends withheld due to losses

Bonus / split / rights

3:4 bonus (23 Aug 1993); no split since 2000; no rights issue since 2000 (Trendlyne; Goodreturns)

Credit ratings (Moody's / S&P / Fitch / Indian agencies)

None. The AR states no debt instruments were issued and no credit ratings obtained

Debt maturity profile

Not disclosed. All borrowings unsecured (₹2.59 Cr principal at 31 Mar 2020); no interest due but unpaid

Share Price

MetricApr2019May2019Jun2019Jul2019Aug2019Sep2019Oct2019Nov2019Dec2019Jan2020Feb2020Mar2020

Share price high (INR)

1.942.102.311.810.880.780.751.261.721.721.771.53

Share price low (INR)

1.941.941.900.920.720.690.680.711.321.691.531.33

Valuation Multiples

MultipleAdvent (at last trade, Feb 2022)Peers

P/E

Not meaningful (losses)

Not compiled (Advent not comparable)

EV/EBITDA

Not meaningful (negative EBITDA)

Not compiled

EV/Sales

Not meaningful (zero sales)

Not compiled

P/B

0.32x

Not compiled

Analyst Conclusions

Management guidance and consensus

Management guidance: None quantitative. The latest qualitative outlook (FY2020 MD&A) expected an acquisition-led revival that has not materialised.

Consensus growth expectations: None (no analyst coverage).

Bull case (three arguments grounded in data)

  1. Statutory exit at fair value could exceed the last traded price. Book value per share was about ₹8.8 at FY2020 against a last trade of ₹2.82 (0.32x P/B). If an independent valuer were to attribute value to the ₹16.8 Cr fixed-asset base, a promoter-funded exit could deliver a premium to minority holders.

  2. Balance-sheet leverage is modest and cash burn has been cut to a minimum. Borrowings of ₹2.65 Cr against net worth of ₹14.33 Cr, and a FY2020 operating cash outflow of only ₹0.13 Cr, mean the company can stay dormant cheaply while the promoter decides its future.

  3. Target markets are growing quickly. Indian telemedicine is estimated at USD 3.1 billion in 2024, growing about 20.5% a year (IMARC). If the promoter group (CCG GmbH and related CCG entities) injected a real telehealth or mobile-payments business, the corporate vehicle could be revived.

Bear case (three arguments grounded in data)

  1. There is no operating business. Revenue fell to zero in FY2020 and stayed there through 9M FY2021, with four employees and nil R&D. No product, contract or partnership has been announced in nearly six years.

  2. Reported equity likely overstates economic value. 94% of assets (₹16.81 Cr) are non-earning fixed assets/CWIP with no depreciation for years, and receivables of ₹82 lakh are about 7.7x the last annual revenue. A realistic impairment would turn net worth negative, which undermines both the bull-case fair value and any exit premium.

  3. Governance and compliance failures culminated in compulsory delisting. These include the 2015 suspension, exchange fines, late ROC filings, a disqualified director, no annual report after FY2020, and delisting in November 2024. Minority holders now hold an illiquid security whose realisation depends on promoter compliance with exit obligations.

Key catalysts and monitorables (next 12 months)

MonitorableWhy it matters
Independent valuer's fair-value determination and any promoter exit offer under the Delisting RegulationsDetermines the realisable value for minority shareholders
MCA filings (AOC-4, MGT-7) for FY2021–FY2026Shows whether the company remains compliant and active, or risks penalties or strike-off
Board composition and CMD status after the Mar 2024 term expiryKey-person and governance continuity
Any statement or transaction by CCG GmbH (53.83% promoter)The promoter is the only party able to fund an exit or a revival
Any SEBI or exchange enforcement on non-compliant promoters/directorsEscalation risk
Dissemination Board disclosures or matched off-market tradesOnly remaining price-discovery mechanism

Concluding analyst verdict

Advent Computer Services Limited is no longer an investable operating company in any conventional sense. It is a 42-year-old corporate vehicle that once had a respectable niche, exporting distribution software for IBM's midrange platforms from Madras in the 1980s and 1990s, and then spent the following two decades on pivots that never generated durable revenue. The ADS 400 franchise faded with its platform. The L&T operating MoU, the 2000 acquisitions, the 2003 Tuxia/TVS set-top-box venture, and the later mobile-banking and telehealth positioning left little trace in the income statement. By FY2020 operating revenue was zero, headcount was four, R&D was nil, and losses were being funded through unsecured loans.

The balance sheet looks solvent on paper, with net worth of ₹14.33 Cr and debt/equity of 0.18x. That comfort is largely illusory: about ₹16.8 Cr of non-earning, unamortised fixed assets carry nearly all the book equity, and receivables appear stale. Governance was weak and compliance chronically late, a pattern that ended in BSE's compulsory delisting effective 27 November 2024. No annual report or quarterly result has been found for any period after December 2020.

For a remaining minority shareholder, the relevant question is not growth or valuation multiples but enforcement. Will the promoter group, led by CCG GmbH with 53.83%, deliver the exit option required by the SEBI Delisting Regulations, and at what independently determined fair value? Until that is resolved, the security is illiquid, informationally opaque and dependent on regulatory action. Any revival thesis would require a promoter asset injection and relisting, for which there is no public evidence.

Verdict: non-investable dormant entity. Monitor solely for exit-offer and regulatory developments. Every operating-business scenario should be treated as speculative and unsupported by disclosed facts.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameDINRoleAppointedTenure (to Oct 2026, if still serving)Background / educationAgeFY2020 compensation

Michael Arul

00,885,978

Chairman & Managing Director (promoter)

22 Feb 1984

42+ years

B.E. (Industrial Production), College of Engineering, Guindy. Former IBM systems engineer (marketing division). Later worked on M&A of software/technology companies in the USA, UK, Australia and Germany. Helped bring supercomputing platforms to NIC, TIFR and the Department of Space. Set up India's first IBM S/38 and AS/400 export software development centres. Other directorships: CCG Technologies India Pvt Ltd, Tecways India Pvt Ltd

80 (born 11 Mar 1946)

Nil (no remuneration due to losses)

Shree Kumar Narayan

07,438,879

Independent Director; Chair of Audit, NRC and SRC

13 Apr 2016 (MCA record shows 28 Sep 2016)

10 years

——

Sitting fees ₹8,000

Kavitha

07,929,620

Independent Director (woman director)

22 Sep 2017

9 years

——

Sitting fees ₹6,000

Parthasarathy Sethuraman

08,278,159

Independent Director

13 Nov 2018

7+ years

——

Sitting fees ₹8,000

Virginie Bompoil

08,104,837

Independent Director (woman director)

13 Nov 2018

7+ years

——

Sitting fees ₹8,000

G. (Ganapathi) Swaminathan

08,829,718

Additional (Independent) Director; proposed for a 5-year term to Sep 2025

20/25 Aug 2020

Term ended Sep 2025 (if confirmed)

Graduate. Legal drafting experience (affidavits, petitions, writs, appeals). Long association with the Directorate of Millets Development, Government of India

75 (born 29 Aug 1951)

Not applicable for FY2020

Shaji John Abraham

01,454,398

Independent Director

—

Ceased 27 Sep 2019 (tenure completed)

——

Sitting fees ₹4,000

Samir Harakhchand Shah

05,192,199

Non-executive, non-independent

22 Sep 2017

Ceased 8 May 2020 (disqualified under Sec 164(2))

Not disclosed; held 35,240 shares

—

Nil

“—” = not publicly disclosed.

Executive Leadership Team

NameTitleFY2020 remuneration (INR)

Michael Arul

Chairman & Managing Director

0

Rahul Jain

Chief Financial Officer

181,200

Vishal Desai

Company Secretary & Compliance Officer

181,200

Directors' Remuneration

FeatureDetail

Board size (31 Mar 2020)

6: 1 executive, 4 independent (incl. 2 women), 1 non-executive non-independent

Chair/CEO separation

No. Michael Arul is both Chairman and Managing Director

Board meetings FY2020

4 (30 May 2019, 14 Aug 2019, 13 Nov 2019, 11 Feb 2020); separate independent directors' meeting 11 Feb 2020

Audit Committee

Chair: Shree Kumar Narayan. Members: Michael Arul (executive), P. Sethuraman, Kavitha, Virginie Bompoil; earlier Shaji John Abraham and Samir Shah. 4 meetings

Nomination & Remuneration Committee

Chair: Shree Kumar Narayan. Members: P. Sethuraman, Virginie Bompoil, Kavitha and Michael Arul (inducted 13 Nov 2019). 4 meetings

Stakeholders' Relationship Committee

Chair: Shree Kumar Narayan. Members: P. Sethuraman, Virginie Bompoil, Michael Arul. 4 meetings. Nil investor complaints received or pending

Governance observations

The executive MD sits on the Audit Committee and the NRC. Best practice would have NRC membership wholly non-executive, and Regulation 19 requires all NRC members to be non-executive. A director was disqualified by MCA (Section 164(2), typically triggered by non-filing at another company). BSE previously fined the company for audit committee composition (Q2 FY2019) and for a late annual report (FY2019); both fines were waived

Board & Management Changes

DateChangeContext

27 Sep 2019

Shaji John Abraham ceases as Independent Director

Completion of tenure

8 May 2020

Samir H. Shah ceases

Disqualification under Sec 164(2)

20/25 Aug 2020

G. Swaminathan appointed Additional Independent Director

Board refresh

30 Sep 2020 (AGM)

Michael Arul re-appointment proposed as CMD, 12 Mar 2021–11 Mar 2024, with remuneration only from surplus profits

Continuation of founder leadership

11 Mar 2024

Arul's approved term as CMD expired. Any further re-appointment is not publicly disclosed

—

After 2020

No disclosed changes; MCA/aggregator records list five directors

—

Major Shareholders

HolderSharesStake (%)Category

CCG GmbH

8,760,00053.83

Promoter (foreign body corporate)

Michael Arul

52,0770.32

Promoter (individual)

Astra Merchandising Pvt Ltd

355,1492.18

Public (body corporate)

Durga Prasad T

184,5121.13

Public (individual)

K Gurava Reddy

175,0001.08

Public (individual)

Sujana B

153,3850.94

Public (individual)

Mahaveer S Danigond

145,0000.89

Public (individual)

Kishor Pravinchandra Parikh

116,0590.71

Public (individual)

Jash Niral Shah

115,0000.71

Public (individual)

Hitesh Rasiklal Thakker

109,7350.67

Public (individual)

Chakrikaa SR

102,5800.63

Public (individual)

Anil Mohanlal Thakker

87,0000.53

Public (individual)

Governance Detail

CategoryMar 2017Mar 2018Mar 2019Mar 2020

Promoters (%)

53.8354.1554.1554.15

DIIs (%)

0.200.200.200.20

Public (%)

45.9745.6545.6545.65

Number of shareholders

9,3148,9528,9298,925

Competitive Landscape

Competitors by Segment

SegmentCompetitorDescriptionRelative positioning vs. Advent

Banking/fintech software (India)

Nucleus Software Exports

Lending and transaction banking software products

Established product company; FY2025 consolidated revenue about ₹839 Cr

Banking/fintech software

Intellect Design Arena

Banking, insurance and capital markets software (eMACH.ai, Purple Fabric)

FY2025 total income about ₹2,577 Cr

Banking/fintech software

Infosys Finacle (Infosys)

Core and digital banking platform

Global scale leader

Banking/fintech software

TCS BaNCS (Tata Consultancy Services)

Banking and financial services platform

Global scale leader

Mobile banking/payments enablement

3i Infotech

Banking and financial services IT products and services

Listed mid-tier peer

Enterprise ERP/distribution software (historical ADS 400 market)

Ramco Systems

Chennai-based ERP, HR/payroll and aviation software

FY2025 revenue ₹5.91b; FY2026 revenue about ₹701 Cr

Enterprise ERP/distribution (historical)

Infor (successor to Intentia's M3 via Lawson)

Global ERP vendor; Intentia was an Advent distribution partner in 1995

Global leader (private)

Telehealth / remote monitoring

Apollo 24/7 (Apollo Hospitals)

Integrated digital health and teleconsultation

Scale leader in Indian digital health

Telehealth

Practo

Teleconsultation and clinic software (private)

Major consumer health platform

Telehealth

Tata 1mg

E-pharmacy and teleconsultation (private, Tata Digital)

Major consumer health platform

Remote monitoring devices

Dozee (private)

Contactless remote patient monitoring

Specialist RPM provider

Small-cap IT services

Saksoft, Kellton Tech Solutions

Digital IT services

Operating small-caps with real revenue

Competitive Advantages & Vulnerabilities

Advantages (limited)Vulnerabilities (severe)

Founder with long industry history (ex-IBM, 40+ years) and links to a foreign promoter group (CCG GmbH)

No revenue, four employees and outsourced delivery: no capability to compete for bank or healthcare contracts

Modest book leverage (debt/equity 0.18x at FY2020)

Delisted. Cannot use listed equity for acquisitions or capital raising, and faces regulatory debarment consequences

Historical credibility in the enterprise software export niche (1980s–1990s)

Zero R&D, no patents, no disclosed proprietary platform in mobile banking or telehealth

—

Stale receivables (₹82 lakh) and large non-earning fixed assets (₹16.8 Cr)

Peer Comparison FY2025

MetricAdvent Computer Services (FY2020, last audited)Nucleus Software Exports (FY2025)Intellect Design Arena (FY2025)Ramco Systems (FY2025)

Revenue (INR Cr)

0.00838.70

2577.03 (total income)

591 (revenue); 596.9 (consolidated income)

Revenue growth YoY (%)

-100.02.8

0.45 (total income)

13

Net profit (INR Cr)

-0.19161.76332.77-34.25

Net margin (%)

n/m

about 19

about 13

about -6

R&D intensity (% of revenue)

0 (nil R&D)

———

Recent Developments

Searches of BSE-mirrored aggregators (Screener, Trendlyne), news databases and corporate-registry aggregators found no company-originated material developments between April 2025 and October 2026**: no product launches, contract wins, results, guidance, leadership changes, litigation or restructurings. Trendlyne shows no mutual fund holdings in every month from July 2023 to October 2026, and no bulk/block deals or insider/SAST disclosures.

Company Snapshot

4

Employees

1984

Founded

SWOT Analysis

Strengths

  • Low book leverage: Borrowings ₹2.65 Cr vs. net worth ₹14.33 Cr at FY2020 (debt/equity 0.18x; Screener)
  • No secured debt or pledged promoter shares: All indebtedness unsecured (₹2.59 Cr); promoter shares 0% pledged (AR FY2020 MGT-9)
  • Long-tenured founder with deep industry network: Michael Arul, CMD since 1984; ex-IBM; M&A experience in four countries (AR FY2020 profile)
  • Majority foreign promoter with a long relationship: CCG GmbH holds 53.83%. The CCG group has been a marketing partner since 1999 and was linked to the 2003 share issue to CCG Global (AR FY2020; company history)
  • Very low cash burn after cost cuts: FY2020 operating cash outflow ₹0.13 Cr vs. ₹0.60 Cr in FY2019; 9M FY2021 losses of ₹0.13 Cr (Screener)
  • Clean audit opinion for FY2020 and nil investor complaints: No qualification, reservation or adverse remark; nil complaints received or pending in FY2020 (AR FY2020)

Weaknesses

  • Zero operating revenue: Nil in FY2020 and each quarter of 9M FY2021 (AR FY2020; Screener)
  • Persistent losses: Net losses of ₹0.52 Cr, ₹0.44 Cr and ₹0.19 Cr in FY2018–FY2020 (Screener)
  • Questionable asset quality: ₹16.81 Cr (94% of assets) in non-earning fixed assets/CWIP with near-nil depreciation since FY2017 (Screener)
  • Stale receivables: Debtors ₹82.15 lakh vs. FY2019 revenue ₹10.69 lakh; debtor days 2,920 in FY2019 (AR FY2020; Screener)
  • Negligible human capital: 4 permanent employees; delivery outsourced (AR FY2020)
  • Compliance weaknesses: BSE fines for audit committee composition (FY2019) and late annual report (FY2020); late ROC/DPT-3 filings; a disqualified director (AR FY2020)

Opportunities

  • High-growth telehealth market: India telemedicine USD 3.1 billion (2024), 20.5% CAGR to 2033 (IMARC)
  • Mobile banking execution partnership: MD&A FY2020 cites talks to be Indian execution partner for an international secure mobile transaction platform
  • Promoter could inject businesses or assets: Promoter-related entities exist (CCG Technologies India, Tecways India; AR FY2020), though no such plan is disclosed
  • Statutory exit offer for minority holders: SEBI Delisting Regulations 2021 framework for compulsory delisting (BSE notice references the Regulations); book value per share of about ₹8.8 vs. last price ₹2.82
  • Monetisation of accumulated tax losses or the corporate shell: Accumulated reserves of -₹1.94 Cr at FY2020 (Screener); utilisation subject to tax law (analytical)
  • Possible relisting after compliance: BSE has a framework for companies seeking revocation (Business Standard, 2016), though compulsory delisting is more severe than suspension

Threats

  • Delisting consequences: Compulsory delisting from 27 Nov 2024. Promoters and whole-time directors barred from directorships of listed companies until the exit option is provided (BSE notice)
  • Capital-raising impossibility: MD&A FY2020 names capital raising as the main threat, and delisting removes equity market access
  • Potential impairment: A writedown of ₹16.8 Cr of fixed assets would wipe out net worth (analytical, based on Screener balance sheet)
  • Key-person risk: CMD aged 80 (born 11 Mar 1946; AR FY2020); his approved CMD term ended 11 Mar 2024
  • Regulatory/registry risk: No annual report found after FY2020; continued non-filing at MCA could lead to penalties or strike-off proceedings (regulatory framework)
  • Intense competition from scaled players: Peers such as Intellect (₹2,577 Cr total income) and Nucleus (₹839 Cr revenue) in FY2025 dominate banking software

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
22 Sep 2026Value Research stock page last updated; still shows last price ₹2.82 (28 Feb 2022) and no TTM revenueConfirms no trading or new financial data in aggregator databases
Jul 2023 – Oct 2026Monthly checks show no MF holdings (Trendlyne)No institutional interest
25 Nov 2024BSE Notice 20241125-24: compulsory delisting effective 27 Nov 2024; company moved to Dissemination BoardMost significant recent event. Ends listed status and triggers regulatory exit and debarment consequences
27 Nov 2024Delisting effectiveShares no longer tradeable on BSE
28 Feb 2022Last BSE trade at ₹2.82 (volume 4,368 shares)Marks the start of the effective suspension period
1 Apr 2021Trading-window closure disclosureLast captured BSE compliance announcement
Feb 2021 (approx.)Q3 FY2021 results: nil revenue, net loss ₹0.08 CrLast financial disclosure found
Nov 2020 (approx.)Q2 FY2021 results and H1 balance sheet: CWIP of ₹3.85 Cr capitalised into fixed assets (₹16.80 Cr)Asset reclassification with no revenue
30 Dec 2020Zauba Corp (MCA data) records last AGM date as 30 Dec 2020Conflicts with the AR's 30 Sep 2020 AGM date; possibly an adjourned meeting or data error
30 Sep 202035th AGM (VC): auditor change to T S R Sivasubramanian; G. Swaminathan appointed; CMD re-appointment to Mar 2024Last AGM documented in a filed annual report
4 Sep 2020FY2020 Annual Report filed with BSELast annual report available
25 Aug 2020Board approves Directors' Report; G. Swaminathan appointed Additional DirectorBoard refresh
28 Jul 2020Secretarial audit report notes late ROC filings and a BSE fine (waived)Compliance weakness
8 May 2020Director Samir Shah ceases (disqualified)Governance red flag
7 Jan 2020BSE waives the ₹49,560 fineCompliance
15 Oct 2019BSE fine for late FY2019 annual reportCompliance
27 Sep 201934th AGM, Madras Race Club, ChennaiLast physical AGM
30 May 2019Board approves related-party IT consulting with CCG Technologies IndiaLast disclosed revenue-generating arrangement

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (%): Segment share of total operating revenue held from 100% in FY2018 to 100% in FY2020.
Advent Computer Services Limited — Revenue by Segment (%)
Series (%)FY2018FY2019FY2020
Segment share of total operating revenue100100100

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Advent Computer Services Ltd, 35th Annual Report FY2020 and AGM Notice (filed with BSE, 4 Sep 2020) (bseindia.com)
  2. Screener.in, Advent Computer Services Ltd (standalone P&L, balance sheet, cash flow, ratios, shareholding, quarterly results, document list) (screener.in)
  3. BSE Notice 20241125-24, Compulsory Delisting of Companies (via PublicNow) (publicnow.com)
  4. Business Standard (PTI), "BSE to suspend trading in 40 securities", 24 Aug 2015 (business-standard.com)
  5. Business Standard (PTI), "Cos seeking revocation of suspension can apply online: BSE" (business-standard.com)
  6. Goodreturns, Advent Computer Services company history (goodreturns.in)
  7. ClearTax, Advent Computer Services company background (cleartax.in)
  8. Aaj Tak, Advent Computer Services share price and profile (aajtak.in)
  9. Business Today, Advent Computer Services share price page (businesstoday.in)
  10. IIFL (IndiaInfoline), Advent Computer Services financials (indiainfoline.com)
  11. Value Research, Advent Computer Services financials (valueresearchonline.com)
  12. PitchBook, Advent Computer Services profile (pitchbook.com)
  13. Tracxn, Advent Computer Services profiles (tracxn.com)
  14. Zauba Corp, Advent Computer Services Limited (MCA data) (zaubacorp.com)
  15. Tofler, Advent Computer Services Limited (tofler.in)
  16. The Company Check, Advent Computer Services Limited (thecompanycheck.com)
  17. Emkay Global, Advent Computer Services company info (emkayglobal.com)
  18. Trendlyne, Advent Computer Services (bulk/block deals, insider trading, MF holdings, splits, rights) (trendlyne.com)
  19. Torus Digital, Nucleus Software Exports FY2025 summary (torusdigital.com)
  20. Simply Wall St, Nucleus Software Exports FY2025 results (simplywall.st)
  21. Business Standard, Intellect Design Arena Q4/FY2025 results (business-standard.com)
  22. Simply Wall St, Ramco Systems FY2025 results (simplywall.st)
  23. Ramco Systems, FY2025 results press release (ramco.com)
  24. FilingReader, Ramco Systems FY2026 results (filingreader.com)
  25. IMARC Group, India Telemedicine Market (imarcgroup.com)
  26. TechSci Research (via GII), India Telemedicine Market (giiresearch.com)
  27. BlueWeave Consulting, India Telemedicine Market (blueweaveconsulting.com)
  28. Custom Market Insights, India Telehealth Market (custommarketinsights.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.